Nwobodo Ndubuisi
Department of Pharmacology and Therapeutics, Ebonyi State University, Abakaliki, PMB 53, Nigeria.
JRSM Open. 2014 Jul 8;5(8):2054270414531121. doi: 10.1177/2054270414531121. eCollection 2014 Aug.
Therapeutic drug monitoring is aimed at using drug concentration measurements to manage a patient's medication requirement and optimise clinical outcome, particularly in respect of drugs with narrow therapeutic index. Typically, immunoassay methods of various techniques are employed with the advantage of rapid turnaround time and ease of operation. The chromatographic methods are specific and cost effective, though more demanding and require technical expertise. The most crucial aspect of any therapeutic drug monitoring service is the expert clinical interpretation of drug concentration measurements taking into consideration individual pharmacokinetic variability in drug disposition across different populations. The setting up of a therapeutic drug monitoring service requires enormous resources, both in terms of equipment and trained personnel. This poses considerable constraints in developing countries due to limited scarce resources, coupled with ignorance among health practitioners on the relevance of therapeutic drug monitoring in clinical practice. Consequently, the need for advocacy, training and encouragement of health practitioners on the usefulness of therapeutic drug monitoring in enhancing patient care and overall clinical outcome in a developing country such as Nigeria can never be over-emphasised.
治疗药物监测旨在通过药物浓度测定来管理患者的用药需求并优化临床结果,尤其是对于治疗指数较窄的药物。通常,会采用各种技术的免疫测定方法,其优点是周转时间快且操作简便。色谱法具有特异性且成本效益高,不过要求更高且需要专业技术知识。任何治疗药物监测服务最关键的方面是对药物浓度测定进行专业的临床解读,要考虑到不同人群在药物处置方面的个体药代动力学变异性。建立治疗药物监测服务在设备和训练有素的人员方面都需要大量资源。由于资源有限,这在发展中国家构成了相当大的限制,再加上卫生从业人员对治疗药物监测在临床实践中的相关性认识不足。因此,在尼日利亚这样的发展中国家,倡导、培训并鼓励卫生从业人员认识到治疗药物监测在改善患者护理和整体临床结果方面的作用,怎么强调都不为过。